Prothena Corp. plc Stock
Prothena Corp. plc Stock
The price for the Prothena Corp. plc stock decreased slightly today. Compared to yesterday there is a change of -€0.032 (-0.430%).
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Prothena Corp. plc.
With a target price of 15 € there is potential for a 105.31% increase which would mean more than doubling the current price of 7.31 € for Prothena Corp. plc.
Our community identified positive and negative aspects for Prothena Corp. plc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Prothena Corp. plc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | -0.430% | -3.640% | -14.689% | 20.760% | -10.902% | -87.511% | -82.769% |
| Evolus Inc | -0.040% | -0.954% | -14.526% | -33.462% | -4.771% | -42.967% | -41.356% |
| Heron Therapeutics Inc. | 1.530% | 3.155% | 15.773% | -72.386% | -61.257% | -69.171% | -95.838% |
| Rhythm Pharmaceuticals | -1.080% | 1.667% | -5.181% | 26.207% | -2.139% | 479.114% | 535.417% |
Comments
Prothena (PRTA) had its "buy" rating reaffirmed by HC Wainwright.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (PRTA) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (PRTA) had its "outperform" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for PRTA provided by MarketBeat